Stanton Mehr | Director of Content
Biosimilars Review & Report

Stanton Mehr, Director of Content, Biosimilars Review & Report

I'm a writer, editor, and publishing executive with more than 35 years of experience in clinical, health policy, managed markets/payer, and pharmaceutical sectors. I have worked extensively as a consultant to the health care communications industry and publishers, as well as project manager for several clients. For the past 12+ years, I have also focused on the evolving biosimilars industry, maintaining a long-running blog (www.biosimilarsrr.com); and consulting on research, access, reimbursement, and policy. Keys to success: Listening closely to the client, having a keen eye for detail, and keeping on top of the industries vital to my organization.

Appearances:



Festival of Biologics Day 1 @ 15:20

Panel: Biosimilar Portfolio Planning & Pipeline Development

last published: 21/Mar/25 16:45 GMT

back to speakers